# Hany Zayed

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hany-zayed/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,044 |
| Field | Peripheral Artery Disease Management |
| h-index | 28 |
| i10-index | 65 |
| Last Known Institution | Guy's and St Thomas' NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5111032529 |
| ORCID iD | 0000-0001-5023-5834 |
| Works | 197 |

## Researcher papers

- [Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study](https://scholariq.org/papers/rovalpituzumab-tesirine-a-dll3-targeted-antibody-drug-conjugate-in-recurrent/)
- [A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial](https://scholariq.org/papers/a-vein-bypass-first-versus-a-best-endovascular-treatment-first-revascularisation/)
- [Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials](https://scholariq.org/papers/fostamatinib-for-the-treatment-of-adult-persistent-and-chronic-immune/)
- [Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes](https://scholariq.org/papers/effects-of-gevokizumab-on-glycemia-and-inflammatory-markers-in-type-2-diabetes/)
- [The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome](https://scholariq.org/papers/the-impact-of-arterial-pedal-arch-quality-and-angiosome-revascularization-on/)
- [Predictors of Outcome after Endovascular Repair for Chronic Type B Dissection](https://scholariq.org/papers/predictors-of-outcome-after-endovascular-repair-for-chronic-type-b-dissection/)
- [Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair](https://scholariq.org/papers/radiation-induced-dna-damage-in-operators-performing-endovascular-aortic-repair/)
- [Is Endovascular Repair of Mycotic Aortic Aneurysms a Durable Treatment Option?](https://scholariq.org/papers/is-endovascular-repair-of-mycotic-aortic-aneurysms-a-durable-treatment-option/)
- [Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program](https://scholariq.org/papers/long-term-fostamatinib-treatment-of-adults-with-immune-thrombocytopenia-during/)
- [Occupational Radiation Exposure During Endovascular Aortic Procedures](https://scholariq.org/papers/occupational-radiation-exposure-during-endovascular-aortic-procedures/)
- [Outcomes and use of healthcare resources after an intervention for chronic limb-threatening ischaemia](https://scholariq.org/papers/outcomes-and-use-of-healthcare-resources-after-an-intervention-for-chronic-limb/)
- [Economic impact of limb-salvage strategies in chronic limb-threatening ischaemia: modelling and budget impact study based on national registry data](https://scholariq.org/papers/economic-impact-of-limb-salvage-strategies-in-chronic-limb-threatening-ischaemia/)

## Researcher topics

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Aortic aneurysm repair treatments](https://scholariq.org/topics/aortic-aneurysm-repair-treatments/)
- [Vascular Procedures and Complications](https://scholariq.org/topics/vascular-procedures-and-complications/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Infectious Aortic and Vascular Conditions](https://scholariq.org/topics/infectious-aortic-and-vascular-conditions/)

## Researcher university

- [Guy's and St Thomas' NHS Foundation Trust](https://scholariq.org/institutions/guy-s-and-st-thomas-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.